Patrick Chauvet

Mr Chauvet is developing iBIONICS’ clinical program and regulatory strategy. He designed the iBIONICS’ pre-clinical development program and oversees execution including protocol design, ethics approvals, and reporting. His experience includes leading pre-clinical and clinical development for novel Class III medical devices from concept to market approval. He has managed multiple international multicentre trials that successfully led to market approvals in Canada, US and EU.